|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
37 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | Abbott says data affirms safety of palivizumab |
2003 |
940 | 1 |
p. 2 |
artikel |
||
| 2 | Abciximab |
2003 |
940 | 1 |
p. 6 |
artikel |
||
| 3 | ACE inhibitors increase restenosis after stent implantation |
2003 |
940 | 1 |
p. 4 |
artikel |
||
| 4 | Alteplase |
2003 |
940 | 1 |
p. 6 |
artikel |
||
| 5 | Antiretrovirals: no increase in CV or cerebrovascular disease rates |
2003 |
940 | 1 |
p. 5 |
artikel |
||
| 6 | Apronalide/ethenzamide |
2003 |
940 | 1 |
p. 6 |
artikel |
||
| 7 | Carbamazepine |
2003 |
940 | 1 |
p. 7 |
artikel |
||
| 8 | Clozapine |
2003 |
940 | 1 |
p. 7 |
artikel |
||
| 9 | Clozapine withdrawal |
2003 |
940 | 1 |
p. 7 |
artikel |
||
| 10 | Finasteride |
2003 |
940 | 1 |
p. 7 |
artikel |
||
| 11 | Fluoxetine/tinzaparin sodium |
2003 |
940 | 1 |
p. 8 |
artikel |
||
| 12 | Fluticasone propionate |
2003 |
940 | 1 |
p. 8 |
artikel |
||
| 13 | Fluticasone propionate does not suppress growth |
2003 |
940 | 1 |
p. 5 |
artikel |
||
| 14 | Further evidence supports safety of thiomersal in vaccines |
2003 |
940 | 1 |
p. 2 |
artikel |
||
| 15 | High serum digoxin concentration associated with increased mortality |
2003 |
940 | 1 |
p. 5 |
artikel |
||
| 16 | HRT: increased risk of recurrent MI in diabetic women |
2003 |
940 | 1 |
p. 3 |
artikel |
||
| 17 | HRT increases risk of heart disease, MI and death in diabetic women |
2003 |
940 | 1 |
p. 3 |
artikel |
||
| 18 | Interferon-α |
2003 |
940 | 1 |
p. 8 |
artikel |
||
| 19 | Lansoprazole |
2003 |
940 | 1 |
p. 8 |
artikel |
||
| 20 | Lithium interaction |
2003 |
940 | 1 |
p. 9 |
artikel |
||
| 21 | Loxoprofen/misoprostol |
2003 |
940 | 1 |
p. 9 |
artikel |
||
| 22 | Megestrol |
2003 |
940 | 1 |
p. 9 |
artikel |
||
| 23 | Palivizumab prophylaxis safe for second RSV season |
2003 |
940 | 1 |
p. 5 |
artikel |
||
| 24 | Paroxetine |
2003 |
940 | 1 |
p. 9 |
artikel |
||
| 25 | PEG-interferon-α-2b |
2003 |
940 | 1 |
p. 9-10 |
artikel |
||
| 26 | Pergolide |
2003 |
940 | 1 |
p. 10 |
artikel |
||
| 27 | Prednisolone |
2003 |
940 | 1 |
p. 10 |
artikel |
||
| 28 | Quetiapine |
2003 |
940 | 1 |
p. 10 |
artikel |
||
| 29 | Rifabutin |
2003 |
940 | 1 |
p. 10-11 |
artikel |
||
| 30 | Sirolimus associated with bronchial anastomotic dehiscence |
2003 |
940 | 1 |
p. 3 |
artikel |
||
| 31 | Spironolactone in heart failure |
2003 |
940 | 1 |
p. 4 |
artikel |
||
| 32 | Tamoxifen |
2003 |
940 | 1 |
p. 11 |
artikel |
||
| 33 | Tenofovir |
2003 |
940 | 1 |
p. 11 |
artikel |
||
| 34 | Thioridazine |
2003 |
940 | 1 |
p. 11 |
artikel |
||
| 35 | Treatment-related lung disorders in childhood cancer survivors |
2003 |
940 | 1 |
p. 3 |
artikel |
||
| 36 | US labelling change for `Permax' |
2003 |
940 | 1 |
p. 2 |
artikel |
||
| 37 | Verteporfin |
2003 |
940 | 1 |
p. 12 |
artikel |
37 gevonden resultaten